536731-65-4
Chemical Structure
GSK-3β inhibitor 11
- CAS. Nr.: 536731-65-4
- Formula:C20H15N3O4S
- Molecular Weight:393.42
IUPAC Name: 2-(1,3-dioxoisoindolin-2-yl)-N-(4-(3-methoxyphenyl)thiazol-2-yl)acetamide
InChIKey: OLPPQDIVHUSKKX-UHFFFAOYSA-N
SMILES: O=C1C2=C(C(N1CC(NC3=NC(C4=CC(OC)=CC=C4)=CS3)=O)=O)C=CC=C2
Biological Activity: GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK-3β inhibitor 11 | 98.02% | GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords